Reactivation of Hepatitis B Virus Associated with Chemotherapy and Immunosuppressive Agent

Authors

  • Indra Wijaya Department of Internal Medicine. Faculty of Medicine, University of Indonesia - Cipto Mangunkusumo Hospital
  • Irsan Hasan Department of Internal Medicine. Faculty of Medicine, University of Indonesia - Cipto Mangunkusumo Hospital

Abstract

Hepatitis B virus (HBV) reactivation after chemotherapy or immunosuppressive therapy is a serious cause of liver-related morbidity and mortality. The mechanism of HBV reactivation is still unclear, but it is believed due to the suppression of immune response hence increasing the viral load. No uniform diagnostic criteria are available, HBV reactivation can be confirmed by an increase in serum HBV-DNA level. There are many consensus regarding this issue, including the type and duration of nucleoside analogue therapy which need to be understood as not all chronic hepatitis B patients will lead to HBV reactivation. Recently, there has been an increased awareness of reactivation of occult hepatitis B virus, especially in hepatitis B virus endemic area, including Indonesia as part of Asia Pacific region. Preempative antiviral therapy was the best approach to prevent the HBV reactivation. Key words: hepatitis B virus reactivation, chemotherapy, immunosuppressive

Downloads

Published

2013-01-01

How to Cite

Wijaya, I., & Hasan, I. (2013). Reactivation of Hepatitis B Virus Associated with Chemotherapy and Immunosuppressive Agent. Acta Medica Indonesiana, 45(1). Retrieved from http://actamedindones.org/index.php/ijim/article/view/123

Issue

Vol. 45 No. 1 (2013)

Section

REVIEW ARTICLE

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.